Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.60
+0.72 (3.02%)
At close: May 15, 2026, 4:00 PM EDT
25.20
+0.60 (2.44%)
After-hours: May 15, 2026, 6:33 PM EDT
Damora Therapeutics Employees
Damora Therapeutics had 7 employees as of December 31, 2025. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$33,584,143
Market Cap
1.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 2 | 40.00% |
| Dec 31, 2024 | 5 | -8 | -61.54% |
| Dec 31, 2023 | 13 | -32 | -71.11% |
| Dec 31, 2022 | 45 | 5 | 12.50% |
| Dec 31, 2021 | 40 | 12 | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 711 |
| Immunocore Holdings | 524 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| KalVista Pharmaceuticals | 275 |
| Biohaven | 274 |
| Maze Therapeutics | 141 |
| Bicara Therapeutics | 103 |
DMRA News
- 4 days ago - Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 15 days ago - Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Damora Therapeutics initiated with an Outperform at RBC Capital - TheFly
- 7 weeks ago - Damora Therapeutics initiated with an Outperform at Evercore ISI - TheFly
- 7 weeks ago - Damora names Peter Harwin chairman, appoints Spyre Therapeutics CEO to board - TheFly
- 7 weeks ago - Damora Therapeutics appoints Jennifer Jarrett as CEO - TheFly
- 7 weeks ago - Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors - GlobeNewsWire
- 2 months ago - Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire